A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2)

Project: Research

Project Details

StatusActive
Effective start/end date10/12/20 → 9/12/25

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • treatment safety
  • cell carcinoma